Weight Loss Drugs

Fuatilia

Wegovy provides heart benefits even with minimal weight loss

A major trial has shown that the weight-loss drug Wegovy reduces cardiovascular risks independently of weight loss. The benefits apply even to those with mild obesity. Researchers analyzed data from over 17,000 participants to reach this conclusion.

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa